Cargando…

Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP

OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yan, Zou, Ying, Liu, Jihua, Wang, Yuanyuan, Chen, Yingbin, Sun, Fang, Yang, Zhi, Cui, Guanghe, Zhu, Xijun, Cui, Xu, Liu, Feifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458917/
https://www.ncbi.nlm.nih.gov/pubmed/36091102
http://dx.doi.org/10.3389/fonc.2022.897596
_version_ 1784786384335142912
author Shi, Yan
Zou, Ying
Liu, Jihua
Wang, Yuanyuan
Chen, Yingbin
Sun, Fang
Yang, Zhi
Cui, Guanghe
Zhu, Xijun
Cui, Xu
Liu, Feifei
author_facet Shi, Yan
Zou, Ying
Liu, Jihua
Wang, Yuanyuan
Chen, Yingbin
Sun, Fang
Yang, Zhi
Cui, Guanghe
Zhu, Xijun
Cui, Xu
Liu, Feifei
author_sort Shi, Yan
collection PubMed
description OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Binzhou Medical University Hospital from 2017 to 2021 were analyzed retrospectively. The patients were randomized into the training and test cohorts with an 8:2 ratio. Radiomics features were extracted from ultrasound images of the primary PTC lesions. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used to select CCLNM positively-related features and radiomics scores were constructed. Clinical features, ultrasound features, and radiomics score were screened out by the Boruta algorithm, and the XGBoost model was constructed from these characteristics. SHapley Additive exPlanations (SHAP) was used for individualized and visualized interpretation. SHAP addressed the cognitive opacity of machine learning models. RESULTS: Eleven radiomics features were used to calculate the radiomics score. Five critical elements were used to build the XGBoost model: capsular invasion, radiomics score, diameter, age, and calcification. The area under the curve was 91.53% and 90.88% in the training and test cohorts, respectively. SHAP plots showed the influence of each parameter on the XGBoost model, including positive (i.e., capsular invasion, radiomics score, diameter, and calcification) and negative (i.e., age) impacts. The XGBoost model outperformed the radiologist, increasing the AUC by 44%. CONCLUSIONS: The radiomics-based XGBoost model predicted CCLNM in PTC patients. Visual interpretation using SHAP made the model an effective tool for preoperative guidance of clinical procedures, including positive and negative impacts.
format Online
Article
Text
id pubmed-9458917
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94589172022-09-10 Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP Shi, Yan Zou, Ying Liu, Jihua Wang, Yuanyuan Chen, Yingbin Sun, Fang Yang, Zhi Cui, Guanghe Zhu, Xijun Cui, Xu Liu, Feifei Front Oncol Oncology OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Binzhou Medical University Hospital from 2017 to 2021 were analyzed retrospectively. The patients were randomized into the training and test cohorts with an 8:2 ratio. Radiomics features were extracted from ultrasound images of the primary PTC lesions. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used to select CCLNM positively-related features and radiomics scores were constructed. Clinical features, ultrasound features, and radiomics score were screened out by the Boruta algorithm, and the XGBoost model was constructed from these characteristics. SHapley Additive exPlanations (SHAP) was used for individualized and visualized interpretation. SHAP addressed the cognitive opacity of machine learning models. RESULTS: Eleven radiomics features were used to calculate the radiomics score. Five critical elements were used to build the XGBoost model: capsular invasion, radiomics score, diameter, age, and calcification. The area under the curve was 91.53% and 90.88% in the training and test cohorts, respectively. SHAP plots showed the influence of each parameter on the XGBoost model, including positive (i.e., capsular invasion, radiomics score, diameter, and calcification) and negative (i.e., age) impacts. The XGBoost model outperformed the radiologist, increasing the AUC by 44%. CONCLUSIONS: The radiomics-based XGBoost model predicted CCLNM in PTC patients. Visual interpretation using SHAP made the model an effective tool for preoperative guidance of clinical procedures, including positive and negative impacts. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9458917/ /pubmed/36091102 http://dx.doi.org/10.3389/fonc.2022.897596 Text en Copyright © 2022 Shi, Zou, Liu, Wang, Chen, Sun, Yang, Cui, Zhu, Cui and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shi, Yan
Zou, Ying
Liu, Jihua
Wang, Yuanyuan
Chen, Yingbin
Sun, Fang
Yang, Zhi
Cui, Guanghe
Zhu, Xijun
Cui, Xu
Liu, Feifei
Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title_full Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title_fullStr Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title_full_unstemmed Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title_short Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
title_sort ultrasound-based radiomics xgboost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: individual application of shap
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458917/
https://www.ncbi.nlm.nih.gov/pubmed/36091102
http://dx.doi.org/10.3389/fonc.2022.897596
work_keys_str_mv AT shiyan ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT zouying ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT liujihua ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT wangyuanyuan ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT chenyingbin ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT sunfang ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT yangzhi ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT cuiguanghe ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT zhuxijun ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT cuixu ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap
AT liufeifei ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap